Peptides and methods using same
US9566347B2 · kind B2 · utility
0Cited by
1References
32Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 7, 2012 |
| Grant date | Feb 14, 2017 |
| Priority date | — |
| Expiry date | Jul 31, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention includes a method of modulating the phagocytic activity of at least one phagocyte in a subject. The present invention also includes a method of providing a composition resistant to phagocytosis to a subject. The present invention further includes a method of treating, ameliorating or preventing an inflammatory disease in a subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.